Skip to main content

Zoetis Inc Cl A(ZTS-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low175.48
Day High179.13
Open:179.00
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
TheNewswire.com
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Zoetis Inc. Investors to Inquire About Securities Class Action Investigation - ZTS
TheNewswire.com
ZTS LOSS ALERT: ROSEN, A LONGSTANDING LAW FIRM, Encourages Zoetis Inc. Investors to Inquire About Securities Class Action Investigation - ZTS
TheNewswire.com
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Zoetis Inc. Investors to Inquire About Securities Class Action Investigation - ZTS
TheNewswire.com
ROSEN, LEADING INVESTOR COUNSEL, Encourages Zoetis Inc. Investors to Inquire About Securities Class Action Investigation - ZTS
TheNewswire.com
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Zoetis Inc. Investors to Inquire About Securities Class Action Investigation - ZTS
TheNewswire.com
ROSEN, A RANKED AND LEADING FIRM, Encourages Zoetis Inc. Investors to Inquire About Securities Class Action Investigation - ZTS
TheNewswire.com
ZOETIS (ZTS) Investor Alert: Kaplan Fox & Kilsheimer LLP Investigates Zoetis Inc. for Potential Securities Law Violations
TheNewswire.com
ZOETIS (ZTS): Kaplan Fox & Kilsheimer LLP Investigates Zoetis and Encourages Investors with Losses to Contact the Firm

Profile

Zoetis Inc. is a leader in the animal health space with a focus on both livestock and companion animals in seven major product categories: vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. Zoetis has a diversified business, which caters to eight core species ' cattle, swine, poultry, fish and sheep (collectively, livestock) and dogs, cats and horses (collectively, companion animals). It directly markets its products to veterinarians and livestock producers. The outstanding growth rate in the companion animal medicines, vaccines and diagnostics sector is being driven by economic development, related increases in disposable income and a rise in pet ownership and spending on pet care.Zoetis has been working on strengthening its product portfolio through acquisitions and deals.